Jinju Chen

Title: Innovations by Jinju Chen in Anti-Tumor Applications

Introduction

Jinju Chen is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmacology, particularly in the development of compounds for cancer treatment. With a total of four patents to her name, her work focuses on innovative solutions for targeting specific proteins involved in tumor growth.

Latest Patents

Jinju Chen's latest patents include groundbreaking inventions such as the ALK protein regulator and its anti-tumor applications. These patents describe a series of compounds designed to degrade specific proteins and inhibit their activity, which can be utilized in tumor and cancer treatments. The compounds are characterized by a general formula that includes a small molecule compound (SMBP), a linker (LIN), and a ubiquitin ligand (ULM). This innovative approach allows for targeted degradation of proteins, offering new avenues for cancer therapy.

Career Highlights

Jinju Chen is affiliated with Shanghaitech University, where she conducts her research and development. Her work has garnered attention for its potential impact on cancer treatment, showcasing her dedication to advancing medical science.

Collaborations

Jinju collaborates with notable colleagues, including Xiaobao Yang and Biao Jiang, who contribute to her research efforts. Their combined expertise enhances the innovative potential of her projects.

Conclusion

Jinju Chen's contributions to the field of anti-tumor applications through her innovative patents highlight her role as a leading inventor in pharmacology. Her work not only advances scientific knowledge but also holds promise for improving cancer treatment outcomes.